SRK, Devgn, Tiger Shroff Get FDA Notice Over Vimal Ad

Advertise with us

Advertise with us

QatarDay

Entertainment

FDA

Shah Rukh Khan, Ajay Devgn and Tiger Shroff Face Maharashtra FDA Notices Over Vimal Elaichi Ad

Mumbai, August 16, 2026: Bollywood actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff have received show-cause notices from the Maharashtra Food and Drug Administration (FDA) over their participation in advertisements for Vima...
Safdarjung Hospital Issues Statement After Allegations by Sonam Wangchuk’s Wife

Safdarjung Hospital has issued an official response following allegations made by the wife of renowned education reformer and climate activist Sonam Wangchuk, who raised concerns regarding the treatment and medical handling provided to her husband. T..
FDA Peptide Restrictions 2026 What Patients Must Know Now

Millions of Americans rely on peptide therapy for healing, metabolic health, and longevity. Now, a major regulatory shake-up is changing everything. The FDA moved 19 widely used peptides to its restricted Category 2 list back in 2023. That single ..
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US

The US Food and Drug Administration has banned the use of red dye No. 3 in food, beverages and ingested drugs, more than 30 years after scientists discovered links to cancer in animals, the agency announced Wednesday. A synthetic color additive ma..
Alzheimer's Drug that Slows Cognitive Decline Gets FDA Approval

The US Food and Drug Administration granted accelerated approval for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. The FDA said the drug is for pati..
U.S. FDA advisers overwhelmingly back Moderna COVID vaccine for ages 6-17

Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age. Around 77 million people in the ..
U.S. FDA approves Gilead's COVID-19 drug for young children

The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's (GILD.O) drug remdesivir. The move comes months after...
U.S. FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co (BMY.N) said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer. The company said it expects the ..
FDA clears use of Lilly's COVID-19 antibody therapy for kids

The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's (LLY.N) COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. The therapy,..

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories